droperidol |
548-73-2 |
Droleptan |
Inapsine |
Dehydrobenzperidol |
Dridol |
Properidol |
Sintodril |
Sintosian |
Inapsin |
Vetkalm |
Halkan |
Deidrobenzperidolo |
Inopsin |
Innovar |
Inappin |
Innovan |
McN-JR-4749 |
Inoval |
Dehidrobenzperidol |
Droperidolum |
Droperidolo |
Leptanal |
Leptofen |
Thalamanol |
Thalamonal |
Innovar-vet |
Dihidrobenzperidol |
R-4749 |
McN-JR 4749 |
component of Innovar |
R 4749 |
NSC 169874 |
3-1-4-(4-fluorophenyl)-4-oxobutyl-3,6-dihydro-2H-pyridin-4-yl-1H-benzimidazol-2-one |
UNII-O9U0F09D5X |
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone |
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone |
1-{1-4-(4-fluorophenyl)-4-oxobutyl-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one |
CHEMBL1108 |
1-1-3-(p-Fluorobenzoyl)propyl-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone |
MLS000028671 |
CHEBI:4717 |
O9U0F09D5X |
2H-Benzimidazol-2-one, 1-1-4-(4-fluorophenyl)-4-oxobutyl-1,2,3,6-tetrahydro-4-pyridinyl-1,3-dihydro- |
Dehydrobenzoperidol |
MFCD00083290 |
NSC169874 |
NSC-169874 |
1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzodimidazol-2(3H)-one |
1-{1-4-(4-Fluoro-phenyl)-4-oxo-butyl-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one |
2H-Benzimidazol-2-one, 1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro- |
NCGC00016504-01 |
CAS-548-73-2 |
Droperidolo DCIT |
SMR000058855 |
DSSTox_CID_2973 |
DSSTox_RID_76811 |
DSSTox_GSID_22973 |
1-{1-4-(4-fluorophenyl)-4-oxobutyl-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzodimidazol-2-one |
Droperidolum INN-Latin |
Neurolidol |
Ina.psi.ne |
Ina.psi.n |
Ino.psi.n |
1-1-4-(p-Fluorophenyl)-4-oxobutyl-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone |
2-Benzimidazolinone, 1-(1-(3-(p-fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)- |
2-Benzimidazolinone, 1-1-3-(p-fluorobenzoyl)propyl-1,2,3,6-tetrahydro-4-pyridyl- |
Droleptan (TN) |
1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one |
1-(1-(4-(4-fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzodimidazol-2-one |
3-1-4-(4-fluorophenyl)-4-oxidanylidene-butyl-2,3,4,5-tetrahydropyridin-4-yl-1~{H}-benzimidazol-2-one |
CCRIS 9070 |
HSDB 3320 |
R4749 |
SR-05000001546 |
INAPSINE (TN) |
EINECS 208-957-8 |
BRN 0579168 |
Droperidol USP |
1-(1-3-(p-fluorobenzoyl)propyl-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone |
1-1-4-(4-fluorophenyl)-4-oxobutyl-1,2,3,6-tetrahydro-4-pyridinyl-1,3-dihydro-2h-benzimidazol-2-one |
Prestwick_705 |
Innovar (Salt/Mix) |
Droperidol USAN:USP:INN:BAN:JAN |
HS-0065 |
Leptanal (Salt/Mix) |
Leptofen (Salt/Mix) |
Spectrum_001220 |
Thalamonal (Salt/Mix) |
Innovar-vet (Salt/Mix) |
Opera_ID_1751 |
Prestwick0_000360 |
Prestwick1_000360 |
Prestwick2_000360 |
Prestwick3_000360 |
Spectrum2_001386 |
Spectrum3_001426 |
Spectrum4_000407 |
Spectrum5_001305 |
SCHEMBL41426 |
BSPBio_000459 |
BSPBio_003132 |
KBioGR_000674 |
KBioSS_001700 |
5-24-02-00388 (Beilstein Handbook Reference) |
MLS000758203 |
MLS001148120 |
MLS001424134 |
MLS002153445 |
DivK1c_000103 |
SPECTRUM1501002 |
SPBio_001372 |
SPBio_002380 |
BPBio1_000505 |
Droperidol (JP17/USP/INN) |
GTPL7172 |
DTXSID6022973 |
HMS500F05 |
KBio1_000103 |
KBio2_001700 |
KBio2_004268 |
KBio2_006836 |
KBio3_002352 |
NINDS_000103 |
HMS1569G21 |
HMS1921B03 |
HMS2051L06 |
HMS2092O16 |
HMS2096G21 |
HMS2232M09 |
HMS3374B05 |
HMS3393L06 |
HMS3652M12 |
HMS3713G21 |
HMS3885N03 |
Pharmakon1600-01501002 |
HY-B1240 |
Tox21_110461 |
BDBM50017705 |
CCG-39004 |
NSC757819 |
s4096 |
STL453109 |
ZINC19796080 |
AKOS015960779 |
Tox21_110461_1 |
AC-3537 |
CCG-101004 |
CS-4886 |
DB00450 |
NC00254 |
NSC-757819 |
VA10777 |
1-1-3-(p-Fluorobenzoyl)propyl-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone |
3-1-4-(4-fluorophenyl)-4-oxo-butyl-3,6-dihydro-2H-pyridin-4-yl-1H-benzimidazol-2-one |
IDI1_000103 |
NCGC00016504-02 |
NCGC00016504-03 |
NCGC00016504-04 |
NCGC00016504-05 |
NCGC00016504-06 |
NCGC00016504-09 |
NCGC00016504-17 |
NCGC00094884-01 |
NCGC00094884-02 |
H920 |
SBI-0051628.P002 |
Droperidol 1.0 mg/ml in Dimethyl Sulfoxide |
FT-0655846 |
SW220019-1 |
D00308 |
F17346 |
AB00052191_04 |
AB00052191_05 |
WLN: T56 BMVNJ D3- DT6N CUTJ A3VR DF |
548D732 |
A830387 |
L001006 |
Q174259 |
SR-05000001546-1 |
SR-05000001546-2 |
SR-05000001546-3 |
W-105600 |
BRD-K97158071-001-05-8 |
BRD-K97158071-001-08-2 |
Droperidol, British Pharmacopoeia (BP) Reference Standard |
Droperidol, European Pharmacopoeia (EP) Reference Standard |
Droperidol, United States Pharmacopeia (USP) Reference Standard |
2H-Benzimidazol-2-one,2,3,6-tetrahydro-4-pyridinyl-1,3-dihydro- |
1-1-3-(p-Fluorobenzoyl)propyl-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone |
1-1-4-(p-Fluorophenyl)-4-oxobutyl-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone |
1-1-3-(p-Fluorobenzoyl)propyl-1,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone |
gamma-4-(2-oxo-1-benzimidazolinyl)-1,2,3,6-tetrahydro-1-pyridyl-p-fluorobutyrophenone |
1-(4-fluorophenyl)-4-4-(2-hydroxy-1H-1,3-benzodiazol-1-yl)-1,2,3,6-tetrahydropyridin-1-ylbutan-1-one |
1-1-4-(4-fluorophenyl)-4-oxo-butyl-3,6-dihydro-2H-pyridin-4-yl-3H-benzoimidazol-2-one |
1-{1-4-(4-Chloro-phenyl)-4-oxo-butyl-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Droperidol) |
1-{1-4-(4-fluorophenyl)-4-oxobutyl-1,2,3,6-tetrahydropyridin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one |
1-{1-4-(4-fluorophenyl)-4-oxobutyl-1,2,5,6-tetrahydropyridin-4-yl -1,3-dihydro-2H-benzimidazol}-2-one |
3-1-4-(4-fluorophenyl)-4-oxidanylidene-butyl-3,6-dihydro-2H-pyridin-4-yl-1H-benzimidazol-2-one |
USS |